Croatia: 288 Ozempic side-effect reports, 19% serious, irreversible cases flagged

Croatian medicines agency HALMED has logged 288 suspected adverse reactions to GLP-1 weight-loss drugs, with 19% classified as serious, including reports of irreversible conditions. The claim of irreversibility is based on patient reports and not yet independently verified; the development adds to growing European scrutiny of GLP-1 safety profiles.